PERNIX THERAPEUTICS HLDGS IN - COM (PTX)

CUSIP: 71426V108

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
34,244,291
Share change
+3,147,945
Total reported value
$365,960,746
Put/Call ratio
33%
Price per share
$10.69
Number of holders
112
Value change
+$35,572,970
Number of buys
71
Number of sells
45

Quarterly Holders Quick Answers

What is CUSIP 71426V108?
CUSIP 71426V108 identifies PTX - PERNIX THERAPEUTICS HLDGS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM (PTX) as of Q1 2015

As of 31 Mar 2015, PERNIX THERAPEUTICS HLDGS IN - COM (PTX) was held by 112 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,244,291 shares. The largest 10 holders included JANUS CAPITAL MANAGEMENT LLC, Consonance Capital Management LP, Broadfin Capital, LLC, KENNEDY CAPITAL MANAGEMENT, INC., BlackRock Fund Advisors, venBio Select Advisor LLC, WALL STREET ASSOCIATES, Allianz Asset Management AG, RK Capital Management, LLC, and ORBIMED ADVISORS LLC. This page lists 112 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.